Roche Holding AG
RHHBY
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,249
Roche Holding AG News & Analysis
stocks
10 best US blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks
The 10 best global companies to invest in now
These undervalued stocks of high-quality companies are attractive investments today.
stocks
5 top US dividend shares from the best managers
These cheap dividend stocks are popular among highly rated concentrated fund managers.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,264.30 | 8.50 | 0.09% |
CAC 40 | 8,045.35 | 3.99 | 0.05% |
DAX 40 | 24,618.14 | 6.89 | 0.03% |
Dow JONES (US) | 46,358.42 | 243.36 | -0.52% |
FTSE 100 | 9,507.57 | 1.83 | -0.02% |
HKSE | 26,290.32 | 462.27 | -1.73% |
NASDAQ | 23,024.63 | 18.75 | -0.08% |
Nikkei 225 | 48,088.80 | 491.64 | -1.01% |
NZX 50 Index | 13,467.26 | 103.60 | -0.76% |
S&P 500 | 6,735.11 | 18.61 | -0.28% |
S&P/ASX 200 | 8,958.30 | 9.20 | 0.10% |
SSE Composite Index | 3,897.03 | 36.94 | -0.94% |